Nabeel Khan, MD

Associate Professor of Clinical Medicine (Gastroenterology)
Director of Gastroenterology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA
Department: Medicine
Contact information
3900 Woodland Avenue
Philadelphia, PA 19104
Philadelphia, PA 19104
Links
Corporal Michael J. Crescenz VA Medical Center
Penn Medicine Inflammatory Bowel Disease Program
Corporal Michael J. Crescenz VA Medical Center
Penn Medicine Inflammatory Bowel Disease Program
Education:
FSC
Islamabad College, Pakistan, 1989.
MD
King Edward Medical College, Pakistan, 1995.
Permanent linkFSC
Islamabad College, Pakistan, 1989.
MD
King Edward Medical College, Pakistan, 1995.
Selected Publications
Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX: Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. Am J Gastroenterol Apr 2024 Notes: doi: 10.14309/ajg.0000000000002761.Khan N, Trivedi C, Shah Y, Patel M, Sundararajan R, Xie D, Yang YX: Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort. J Clin Gastroenterol 58(3): 277-280, Mar 2024.
M C Dubinsky, M Gianfrancesco, G Gauthier, L Fallon, G R Lichtenstein, N H Khan, G Y Melmed, S Hanauer, T Ritter, G Bell, Y C Lee, N Kulisek, A Yndestad, D T Rubin: Assessment of steroid use in patients with active ulcerative colitis who initiated a new Janus kinase inhibitor or tumour necrosis factor inhibitor using data from a United States claims database. Journal of Crohn's and Colitis Jan 2024.
Sundararajan, Ramaswamy MBBS1; Patel, Manthankumar MBBS, MS1; Trivedi, Chinmay MD2; Khan, Nabeel : 5-Year Outcomes of Adalimumab Use in Nationwide Cohort of Bio-Naïve Ulcerative Colitis Patients. The American Journal of Gastroenterology Oct 2023.
Chiorean M, Ha C, Hur P, Sharma PP, Gruben D, Khan N: Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database. Dig Dis Sci 68(10): 3985-399, Oct 2023.
Polson MK, Bahrain H, Ogden JF, Utkina K, Bucco RA, Khan N: Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia. J Manag Care Spec Pharm 29(7): 818-824, Jul 2023.
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W: Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 57(7): 800-80, Apr 2023.
N Khan, N Mahmud, M Patel, R Sundararajan, W Reinisch: Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of Inflammatory Bowel Disease patients. Journal of Crohn's and Colitis Feb 2023.
N Khan, M Patel, R Sundararajan: Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients. Journal of Crohn's and Colitis Feb 2023.
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W: Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of IBD patients. Clin Gastroenterol Hepatol Dec 2022.